Related Experiment Videos

[Treatment of bronchiectasis in children]

A Iu Razumovskiĭ, A M Sharipov, S Kh M Bataev

    Khirurgiia
    |September 13, 2012
    PubMed

    Insights

    Thoracoscopic surgery is a preferable, minimally invasive option for treating bronchiectasis in children compared to traditional thoracotomy. This approach leads to shorter recovery times and hospital stays.

    Area of Science:

    • Pediatric Surgery
    • Thoracic Surgery
    • Minimally Invasive Procedures

    Background:

    • Bronchiectasis is a chronic lung condition requiring surgical intervention in some pediatric cases.
    • Traditional thoracotomy involves significant surgical trauma.
    • Evaluating less invasive surgical options is crucial for pediatric patient outcomes.

    Purpose of the Study:

    • To compare the efficacy and outcomes of thoracoscopic surgery versus traditional thoracotomy for pediatric bronchiectasis.
    • To assess operative time, recovery, and hospital stay between the two surgical approaches.

    Main Methods:

    • A comparative study involving two groups of pediatric patients with bronchiectasis.
    • Group 1: Thoracoscopic surgery (n=18).
    • Group 2: Traditional thoracotomy (n=26).

    Main Results:

    • Thoracoscopic surgery had comparable operative times (78.3 min) to thoracotomy (81.7 min).
    • Pleural draining was significantly shorter in the thoracoscopic group (1.3 days) versus thoracotomy (3.3 days).
    • Postoperative hospital stay was reduced with thoracoscopy (9.93 days) compared to thoracotomy (14.4 days). Conversion to thoracotomy was required in 4 cases.

    Conclusions:

    • Thoracoscopic surgery offers a minimally invasive and preferable alternative for pediatric bronchiectasis treatment.
    • Shorter recovery and hospital stay favor the thoracoscopic approach in pediatric patients.
    • Further research may explore expanding indications for thoracoscopic procedures in pediatric thoracic surgery.

    Related Concept Videos

    Pulmonary Cycle: Exhalation01:17

    Pulmonary Cycle: Exhalation

    In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    Cystic Fibrosis: Management01:24

    Cystic Fibrosis: Management

    Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
    Sinus disease and chronic sinusitis...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: